OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Từ khóa
trừu tượng
Sự miêu tả
SPECIFIC AIM 1:
To conduct a randomized controlled trial (RCT) to determine the efficacy of osteopathic manual treatment (OMT) vs sham OMT in subjects with type 2 diabetes mellitus (T2DM) and comorbid chronic low back pain (LBP). This will involve a 12-week protocol to study changes in response to OMT in such outcomes as LBP severity (primary outcome measure), somatic dysfunction, renal function, glycemic control, and other biomarkers potentially related to T2DM.
SPECIFIC AIM 2:
Within the RCT, to corroborate previous findings indicating that patients with T2DM have a high prevalence of tissue texture abnormalities in the T11-L2 spinal segmental region and to determine if such findings can be statistically associated with the presence of diabetic nephropathy using such laboratory measures as serum creatinine, urinary microalbuminuria and macroalbuminuria, and the glomerular filtration rate.
SPECIFIC AIM 3:
Within the RCT, to explore potential mechanisms of action of OMT by longitudinally measuring concentrations of biomarkers such as insulin, glucagon, cortisol, hemoglobin A1c, tumor necrosis factor-α,interleukin (IL)-1β, IL-6, IL-10, and IL-18 in subjects with T2DM and comorbid chronic LBP over 12 weeks. Significant changes in biomarker concentrations may help explain the effects of OMT and whether such effects are mediated by changes in somatic dysfunction.
ngày
| Xác minh lần cuối: | 04/30/2016 |
| Đệ trình đầu tiên: | 01/30/2014 |
| Đăng ký ước tính đã được gửi: | 01/30/2014 |
| Đăng lần đầu: | 02/03/2014 |
| Cập nhật lần cuối được gửi: | 05/23/2016 |
| Cập nhật lần cuối đã đăng: | 05/25/2016 |
| Ngày bắt đầu nghiên cứu thực tế: | 04/30/2014 |
| Ngày hoàn thành chính ước tính: | 07/31/2015 |
| Ngày hoàn thành nghiên cứu ước tính: | 07/31/2015 |
Tình trạng hoặc bệnh tật
Can thiệp / điều trị
Other: Osteopathic Manual Treatment (OMT)
Other: Sham OMT
Giai đoạn
Nhóm cánh tay
| Cánh tay | Can thiệp / điều trị |
|---|---|
| Experimental: Osteopathic Manual Treatment (OMT) The OMT protocol will be delivered following an examination for somatic dysfunction at each treatment session. The protocol will target the thoracic, lumbosacral, iliac, and pubic regions using the following techniques: high-velocity, low-amplitude thrusts; moderate-velocity, moderate-amplitude thrusts; soft tissue including stretching, kneading, and pressure; myofascial stretching and release; counterstrain; muscle energy; and other optional techniques as time permits and indicated. The intervention will be delivered at weeks 0, 1, 2, 4, 6 and 8. Week 12 is a data collection visit with no intervention. | Other: Osteopathic Manual Treatment (OMT) Osteopathic Manual Treatment (OMT) is a system of hands-on techniques used by osteopathic physicians to increase function and reduce pain. |
| Sham Comparator: Sham OMT Sham OMT will involve hand contact, active and passive range of motion, and sham techniques that simulate OMT (including optional OMT techniques), but that utilize such maneuvers as light touch, improper patient positioning, purposely misdirected movements, and diminished provider force. Sham OMT will be delivered at weeks 0, 1, 2, 4, 6 and 8. Week 12 is a data collection visit with no intervention. | Other: Sham OMT Sham OMT involves hand contact, active and passive range of motion, and sham techniques that simulate OMT, but that utilize such maneuvers as light touch, improper patient positioning, purposely misdirected movements, and diminished provider force. |
Đủ tiêu chuẩn
| Tuổi đủ điều kiện để học | 18 Years Đến 18 Years |
| Giới tính đủ điều kiện để nghiên cứu | All |
| Chấp nhận tình nguyện viên lành mạnh | Đúng |
| Tiêu chí | Inclusion Criteria: 1. Fasting plasma glucose ≥126 mg/dL; OR 2. Oral glucose tolerance test ≥200 mg/dL; OR 3. HbA1c ≥6.5% AND 4. Low back pain on most days for past three months; AND 5. Usual low back pain severity of 4 or greater on an 11 point numerical scale during the past week. Exclusion Criteria: 1. age less than 18 years or age greater than 79 years; OR 2. having a previous or current diagnosis of type 1 diabetes mellitus; OR 3. having a history of any of the following pancreatic or related disorders: (a) acute or chronic pancreatitis, (b) pancreatic tumor or cancer, (c) Zollinger-Ellison syndrome, or (d) any other medical or surgical condition resulting in functional hypo- or hyperglycemia; OR 4. having end-stage renal disease; OR 5. having a history of any surgery involving the pancreas; OR 6. having a history of low back surgery in the past year; OR 7. receiving workers' compensation benefits in the past three months; OR 8. having involvement in ongoing litigation relating to diabetes mellitus or back problems; OR 9. having a history of a stroke or transient ischemic attack in the past year; OR 10. having used intravenous, intramuscular or oral corticosteroids within the past month; OR 11. attending a manual treatment session (OMT or any manual therapies delivered by chiropractors or physical therapists) in the past three months, or more than three times in the past year; OR 12. practicing osteopathic medicine, chiropractic, or physical therapy, or attending a corresponding professional school; OR 13. being pregnant; OR 14. currently participating in another medical research study Subjects will also be excluded if any of the following conditions are found during the clinical screening: 1. presence of "red flag" conditions relating to LBP (cancer at any anatomical site, spinal osteomyelitis, spinal fracture, herniated disc, ankylosing spondylitis, or cauda equina syndrome); OR 2. angina or congestive heart failure symptoms with minimal activity; OR 3. active bleeding or infection in the lower back, or any other condition that might impede protocol implementation; OR 4. discovery of the presence of any telephone screening exclusion criterion (EXCEPT that the usual LBP severity over the past week may have declined from ≥4/10 points to ≥3/10 points during the lag time between screenings). |
Kết quả
Các biện pháp kết quả chính
1. Change in low back pain severity [12 weeks]
Các biện pháp kết quả thứ cấp
1. Change in back-specific functioning [12 weeks]
2. Change in general health [12 weeks]
3. Change in glycemic control [12 weeks]
4. Tissue texture changes [12 weeks]
5. Change in biomarker concentrations [12 weeks]
